H. pylori Eradication complementary strategy for Vitiligo Management, suggests study Dr. Shravani Dali26 Feb 2026 8:15 PM ISTThe findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H....
Acupuncture May Reduce Itching in Atopic Dermatitis: Study Dr Riya Dave25 Feb 2026 10:00 PM ISTAcupuncture can relieve itch in patients with atopic dermatitis (AD), but it does not improve the severity of the disease significantly, as per the...
Psoriatic Arthritis Strongly Linked to Metabolic Syndrome, finds study Jacinthlyn Sylvia25 Feb 2026 8:30 PM ISTA new meta-analysis published in the recent issue of Clinical Rheumatology journal revealed that metabolic syndrome (MetS) is significantly more...
Cetaphil Healthy Renew, new anti aging range containing purified peptides launched MD Tech25 Feb 2026 4:44 PM ISTThe range focuses on 9 signs of facial ageing, including fine lines, wrinkles, uneven tone and texture, loss of firmness and elasticity, reduced...
Maternal Prenatal Depression Linked to Eczema Risk in Offspring: Study Jacinthlyn Sylvia24 Feb 2026 8:30 PM ISTA new study published in the Frontiers in Pediatrics revealed that maternal depression or anxiety during pregnancy may be associated with an...
Bimekizumab Sustains QoL Gains to 3 Years in Psoriasis: JAMA Dr Riya Dave23 Feb 2026 8:45 PM ISTAccording to a new study published in JAMA Dermatology by Matthias A. and colleagues bimekizumab led to rapid and sustained improvements in symptoms...
Rezpegaldesleukin Shows Sustained Benefit in Moderate-to-Severe Atopic Dermatitis in Phase 2 b trial Dr. Kamal Kant Kohli22 Feb 2026 8:15 PM ISTThe phase 2b REZOLVE-AD trial enrolled 393 adults with moderate-to-severe atopic dermatitis across approximately 110 global sites, randomizing them to...
No Overall Association Between Atopic Dermatitis and Contact Sensitization,suggests study Dr. Shravani Dali20 Feb 2026 8:30 PM ISTResearchers have found in a new study that there is no general association between atopic dermatitis (AD) and contact sensitization (CS). However,...
Weekly Subcutaneous Anifrolumab Improves Disease Control in Lupus: Phase 3 TULIP-SC Trial Medha Baranwal19 Feb 2026 8:30 PM ISTUSA: Subcutaneous anifrolumab significantly improved disease control in adults with moderate to severe systemic lupus erythematosus (SLE) who remained...
Ixekizumab and tirzepatide combo Improves Skin Clearance and Weight Loss in Psoriasis Patients with Obesity: Study Dr. Kamal Kant Kohli19 Feb 2026 8:45 AM ISTNew findings indicate that in adults with moderate-to-severe plaque psoriasis who are overweight or obese, combined treatment with ixekizumab (Taltz)...
Understanding Chest Acne with Dermatologist Dr Radhika Kopikar Kamakshi18 Feb 2026 12:00 PM ISTAcne doesn't always play by the rules. In this video, dermatologist Dr Radhika Kopikar explains why chest acne occurs and how to effectively manage...
New tyrosine kinase 2 inhibitor shows Promising Safety and Efficacy in Atopic Dermatitis: JAMA Jacinthlyn Sylvia17 Feb 2026 9:00 PM ISTA new study published in the Journal of the American Medical Association showed that in the treatment of atopic dermatitis (AD), once-daily oral...
